... article titled: “Another San Antonio biotech changing its name and CEO – San Antonio Business Journal” with publication date: February 26, 2019.
News
- How Many Bristol-Myers Squibb Company (NYSE:BMY)'s Analysts Are Bullish?
- Oncolytics Biotech(R) Presents Biomarker Data in Second-line Pancreatic Cancer at AACR
... Oncolytics Biotech, and his colleagues, in collaboration with Northwestern University, UT Health San Antonio and Adaptive Biotechnologies, can be ...
- China drafts rules on biotech after gene-editing scandal
BEIJING (AP) — China has unveiled draft regulations on gene editing and other potentially risky biomedical technologies after a Chinese scientist's ...
- Celcuity Reports Fourth Quarter and Full Year 2018 Financial Results
We signed a clinical trial agreement with Puma Biotechnology, Inc. and ... the Miami Breast Cancer Conference, and the San Antonio Breast Cancer ...
- Rapamycin Holdings Changes Name to Emtora Biosciences, Hires New CEO
San Antonio — Rapamycin Holdings, a life sciences business working to commercialize a new formulation of an immunosuppressant as a prostate ...